People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Other Technology, Pharma, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ellipse Technologies Inc | — | Other Technology | Series B | $75.4M | $304.6M | 2009 |
| Viseon, Inc. | — | Other Technology | Series B | $32.0M | $20.0M | 2020 |
| Reverse Medical Corp | — | Other Technology | Series A | $28.1M | $383.1M | 2009 |
| Micardia Corp | — | Other Technology | Series A | $20.7M | $102.5M | 2010 |
| Rebound Therapeutics Corp | — | Pharma | Series B | $20.3M | $561.1M | 2015 |
| Onset Medical Corp | — | Other Technology | Seed | $12.3M | $72.9M | 2009 |
| Interventional Spine Inc | — | Other Technology | Seed | $8.1M | $117.2M | 2011 |
| B2M Medical, Inc. | — | Healthtech | Pre-Seed | $825K | $12.6M | 2022 |
| Magellan Spine Technologies Inc | — | Other Technology | Pre-Seed | $618K | $26.2M | 2009 |
Michael R. Henson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael R. Henson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.